Showing results (171-180 of 219) with videos related to
Sort By:
Pageof 22
Molecular Pharmacology|March 1, 1992
Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infectionJ K Sastry, P N Nehete, S Khan, et al.Cancer Research|December 1, 1994
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivoV Grégoire, N T Van, L C Stephens, et al.Pediatric Dermatology|September 13, 2011
Neonatal linear immunoglobulin a bullous dermatosis: a rare presentationMeena R Julapalli, Kirra L Brandon, Cecilia M Rosales, et al.Leukemia|March 1, 1996
Acute lymphoblastic leukemia following preleukemic syndromes in adultsS M Escudier, M Albitar, L E Robertson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulationS R Patel, V Gandhi, J Jenkins, et al.Leukemia|August 1, 1994
Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinosideH M Ghaddar, W Plunkett, H M Kantarjian, et al.Leukemia|September 10, 2011
MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AMLB Z Carter, D H Mak, Y Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisisS J Iacoboni, W Plunkett, H M Kantarjian, et al.Biochemical Pharmacology|October 12, 1995
Biochemical pharmacology of penclomedine (NSC-338720)J A Benvenuto, W N Hittelman, L A Zwelling, et al.Hematology and Cell Therapy|December 1, 1996
Clinical experience with fludarabine in hemato-oncologyM J Keating, S O'Brien, P McLaughlin, et al.Pageof 22